“We’re setting a new standard for healthcare technology. We teach our AI using the health system’s own data, which enables our models to dramatically outperform generic ones like OpenAI’s GPT-4, at lower cost,” said Varun Ganapathi, CTO and co-founder of AKASA. “Our AI can provide coding recommendations along with supporting quotes taken directly from clinical documentation. This is something that’s never been done before. We can now peer inside the black box and therefore work alongside AI to reach far greater heights.
AKASA is a HIPAA-compliant, HITRUST-certified, and SOC 2-certified company. For more information, please visit AKASA.com/Coding.
About AKASA
AKASA is the preeminent provider of end-to-end generative AI solutions for the healthcare revenue cycle. Our offerings are built on the AKASA platform, which integrates the company’s proprietary generative AI technology and deep revenue cycle expertise to deliver exceptional impact for hospitals, health systems, and the patients they serve. AKASA is the only AI company whose technology is trained on a health system’s own clinical data, enabling AI to better understand the specific nuances of a health system. AKASA helps healthcare organizations improve revenue outcomes, achieve greater efficiency, empower staff, and allocate resources where they matter most.
Back to HCB News
